Co-Trimoxazole Prophylaxis Is Associated with Reduced Risk of Incident Tuberculosis in Participants in the Swiss HIV Cohort Study

Co-trimoxazole reduces mortality in HIV-infected adults with tuberculosis (TB), and in vitro data suggest potential antimycobacterial activity of co-trimoxazole. We aimed to evaluate whether prophylaxis with co-trimoxazole is associated with a decreased risk of incident TB in Swiss HIV Cohort Study...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Hasse, Barbara, Walker, A. Sarah, Fehr, Jan, Furrer, Hansjakob, Hoffmann, Matthias, Battegay, Manuel, Calmy, Alexandra, Fellay, Jacques, Di Benedetto, Caroline, Weber, Rainer, Ledergerber, Bruno
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2014
Matèries:
Epidemiology and Surveillance
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4023723/
https://ncbi.nlm.nih.gov/pubmed/24514096
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01868-13
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars